(MENAFN- EIN Presswire) EINPresswire/ -- "Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors

What Is The Forecast For The Muscle Relaxant Drugs Market From 2024 To 2029?
In the recent past, the market size for muscle relaxant drugs has witnessed robust growth. The market is projected to expand from $4.77 billion in 2024 to $5.11 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. The growth observed during the history of the industry can be credited to changes in treatment strategies, management of chronic pain, innovations in pharmaceutical formulations, an increase in surgical procedures, and the growth of physical rehabilitation practices.

The market for muscle relaxant medications is projected to experience robust growth in the upcoming years, increasing to a value of $6.9 billion in 2029 with a compound annual growth rate (CAGR) of 7.8%. This surge during the predicted period can be credited to factors such as integrated pain management strategies, an aging demographic and chronic ailments, exploration in directed therapies, focus on non-medication pain reduction, and progressive developments in pain management therapies. Key trends expected in the future period encompass advancements in profiles of adverse effects, individualized medicinal practices, studies in alternative therapies, the incorporation of muscle relaxants in pain management procedures, and the introduction of botulinum toxin injections.

Download a free sample of the muscle relaxant drugs market report:

What Are The Core Growth Drivers Shaping The Future Of The Muscle Relaxant Drugs Market?
The muscle relaxant drugs market is set to benefit from a growing elderly population. This refers to individuals aged 65 years or older who have a higher tendency to experience musculoskeletal disorders. Such conditions can be effectively treated with muscle relaxant drugs, which offer sedative effects and pain relief. As per the World Health Organization's estimates in October 2022, the Switzerland-based international public health organization, the population of people aged 60 years and over is expected to surge from 1 billion in 2020 to 1.4 billion by 2022. Furthermore, by 2030, one in every six individuals worldwide will be over 60 years old. All things considered, this increase in the elderly population worldwide fuels the need for muscle relaxant drugs.

Which Companies Are Currently Leading In The Muscle Relaxant Drugs Market?
Major players in the Muscle Relaxant Drugs include:
. Pfizer Inc.
. Ipsen Pharma SA
. Teijin Limited
. Par Pharmaceutical Companies Inc.
. Orient Phaarma Co. Ltd.
. Novartis AG
. Accord Healthcare Ltd.
. Amneal Pharmaceuticals LLC
. Fresenius Kabi India Pvt. Ltd.
. Aurobindo Pharma Ltd.

What Are The Top Trends In The Muscle Relaxant Drugs Industry?
In the muscle relaxant drug market, the leading trend is product innovations. Top firms in the market are producing unique drugs for specific medical uses, such as generic muscle relaxant drugs, muscle relaxants for animals, and drugs with flexible and customized dosing to maintain their market position. For example, in June 2022, Amneal Pharmaceuticals Inc., an integrated specialty pharmaceutical firm based in the US, introduced LYVISPAH, a baclofen oral granule (5, 10, and 20 mg) specialized product that received approval from the US Food and Drug Administration to treat spasticity seen in multiple sclerosis and other spinal cord disorders. LYVISPAH is flexible and offers customized dosing with 5 mg, 10 mg, and 20 mg single-dose packets of granules for treating muscle stiffness, spasms, and pain in multiple sclerosis patients. These fast-dissolving flavored granules are an alternative for patients with spasticity who struggle to swallow pills. The product can be taken directly into the mouth with or without water, combined with liquids or food, or via an enteral feeding tube.

Comparative Analysis Of Leading Muscle Relaxant Drugs Market Segments
The muscle relaxant drugs market covered in this report is segmented –
1) By Drug Type: Facial Muscle Relaxant Drugs, Skeletal Muscle Relaxant Drugs, Neuromuscular Blocking Agents
2) By Formulation: Cyclobenzaprine, Carisoprodol, Chlorzoxazone, Metaxalone, Methocarbamol, Baclofen, Tizanidine, Orphenadrine, Dantrolene
3) By Route Of Administration: Oral, Injectable, Spray, Ointment
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:
1) By Facial Muscle Relaxant Drugs: Botulinum Toxin, Dysport, Xeomin
2) By Skeletal Muscle Relaxant Drugs: Centrally Acting Muscle Relaxants, Peripherally Acting Muscle Relaxants
3) By Neuromuscular Blocking Agents: Non-Depolarizing Agents, Depolarizing Agents

View the full muscle relaxant drugs market report:

Which Regions Are Dominating The Muscle Relaxant Drugs Market Landscape?
In 2024, North America led in the market share for muscle relaxant drugs and is predicted to continue its growth. The report on this market includes regions of Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Reports Similar to the Global Muscle Relaxant Drugs Market 2025, By The Business Research Company

Drug Delivery Devices Global Market Report 2025

Drugs For Immunotherapy Global Market Report 2025

Drugs For Hormonal Replacement Therapy Global Market Report 2025

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email:...
The Business Research Company -

Follow Us On:
. LinkedIn: "

MENAFN23112025003118003196ID1110386249